1. Can serum progranulin level be used as a prognostic biomarker in non-small cell lung cancer?
   Nevin Taci Hoca et al, 2022, Monaldi Archives for Chest Disease CrossRef
2. Changes in glycocalyx-related biochemical parameters during lung resection in non-small cell carcinoma cases : A pilot study
   Salih Cokpinar et al, 2022, Medical Science and Discovery CrossRef
3. A Lipid Metabolism-Based Seven-Gene Signature Correlates with the Clinical Outcome of Lung Adenocarcinoma
   Tianqi Li et al, 2022, Journal of Oncology CrossRef
4. Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer
   Zhaoyin Wang et al, 2022, Journal of Healthcare Engineering CrossRef
5. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
   Talip Zengin et al, 2021, Journal of Personalized Medicine CrossRef
6. Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins PHD1 and PHD2 but Not PHD3 Are Decreased in Primary Tumours and Correlate with Poor Prognosis of Patients with Surgically Resected Non-Small-Cell Lung Cancer
   Ana Koren et al, 2021, Cancers CrossRef
7. High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients
   Justyna Durślewicz et al, 2022, Discover Oncology CrossRef